The global prefilled syringes market size is anticipated to reach USD 16.73 billion by 2030, expanding at a CAGR of 13.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.

The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. According to American Pharmaceutical Review in December 2021, COVID-19 vaccines are being created at an unprecedented rate in response to the worldwide pandemic. COVID-19 vaccination doses totaled 7.3 billion by November 9, 2021, with approximately 30.3 million doses provided daily.

As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes. For instance, in March 2022, Schott announced further investments in its pharma sector, including expanding its capacity in Hungary for prefillable glass syringe production. The increased capacity is likely to benefit the global market and provide greater supply security for major pharmaceutical corporations and contract manufacturing firms. As a result, due to the outbreak of coronavirus infection in 2020, sales of prefilled syringes increased globally.

Furthermore, emergency syringes used to treat some of COVID-19's most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list. For instance, in October 2019, Premier Inc. teamed up with Amphastar Pharmaceuticals, Inc. to provide phytonadione injection and emergency, pre-filled syringes of sulphate, dextrose, sodium bicarbonate, epinephrine, atropine, calcium chloride, and lidocaine to healthcare practitioners through its ProvideGx programme. These characteristics are projected to generate lucrative market growth prospects.

Prefilled Syringes Market Report Highlights

• The disposable segment accounted for the largest market share of 91.4% in 2023 and is expected to register the fastest CAGR over the forecast period.
• The glass segment accounted for the largest share of 51.4% in 2023. The glass acts as a strong barrier against external elements like moisture, oxygen, and light.
• The vaccines and immunizations segment accounted for the largest share of 25.8% in 2023. Numerous vaccines require multiple doses to be administered over a period of time.
• The Europe prefilled syringes market dominated the global market and is driven by the strong preference of medical professionals for injectable devices that are prefilled to reduce damage caused by needles.

Prefilled Syringes Market Segmentation

Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and region:

Prefilled Syringes Type Outlook (Revenue, USD Million, 2018 - 2030)

• Disposable
• Reusable

Prefilled Syringes Material Outlook (Revenue, USD Million, 2018 - 2030)

• Glass
• Plastic

Prefilled Syringes Application Outlook (Revenue, USD Million, 2018 - 2030)

• Vaccines & Immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune Diseases
• Oncology
• Others

Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers

Prefilled Syringes Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players

• BD
• Gerresheimer AG
• SCHOTT Pharma AG
• Stevanato Group
• Nipro Corporation
• Terumo
• West pharmaceuticals
• Fresenius
• Catalent
• Aptar Pharma

Recent Developments

• In May 2023, Schott Pharma developed pre-fillable syringes specifically designed for medications that require storage in extremely cold conditions
• In May 2023, Fresenius Kabi expanded its Simplist prefilled syringe line with a 100mcg per 2mL dose of Fentanyl Citrate Injection
• In September 2022, Becton Dickinson and Company (BDX) launched a new, top-of-the-line glass pre-fillable syringe specifically for vaccines. This innovative product features enhanced specifications for manufacturability, visual quality, contamination control, and overall integrity
• In May 2022, SCHOTT, opened a brand-new facility to manufacture pre-fillable syringes using innovative polymer materials

Order a free sample PDF of the Prefilled Syringes Market Intelligence Study, published by Grand View Research.